demonstrated that CD169+ subcapsular sinus (SCS) macrophages are able to phagocytose dead tumor cells transported through the lymphatic fluid in the TDLN and cross-present tumor antigens to CD8+ T cells to activate anti-tumor immune responses (54). Here, SIGLEC1 is linked to neoplasm.